Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Sprout Health vs Gala Health

Sprout Health
Graded #12

Level

vs
Gala Health
Graded #9

Level

The verdict

Too close to call — both grade 86/100 (B).

Sprout Health and Gala Health land on the same WeighScore, so neither clears the other on our six graded dimensions. Gala Health sits one line higher on the board (#9 vs #12) on the underlying tiebreak, but it's a genuine coin-flip — pick on the factors and prices that matter most to you below.

Assume any provider we list may compensate us — we may earn a commission at no cost to you. It never changes the WeighScore.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueEven
90
90
Dose & formulationGala Health +1
82
83
Clinical oversightSprout Health +3
88
85
Labs & monitoringSprout Health +9
92
83
FulfillmentGala Health +10
78
88
Contract termsGala Health +2
84
86
Sprout Health · left barGala Health · right bar

The numbers

MetricSprout HealthGala Health
WeighScore86/10086/100
GradeBB
Scorecard rank#12#9
Semaglutide$149/moNot disclosed
Tirzepatide$199/mo$179/mo
CoverageNot disclosedAll 50 states
Brand-name accessYesYes
Oral / sublingualInjection onlyInjection only
Sprout Health

Graded #12 · B

Strengths

  • LegitScript-certified with a listed address and contact line
  • Both compounded ($149 semaglutide / $199 tirzepatide) and a genuine brand-name Wegovy/Zepbound route
  • Low-friction intake — no labs and often no telehealth visit required

Where it loses points

  • Compounded semaglutide and tirzepatide are not FDA-approved
  • No oral or sublingual route — injectable only
  • Thin transparency — no named medical director, and state availability is quiz-gated
  • "No labs, no visit" convenience also means lighter clinical oversight
Gala Health

Graded #9 · B

Strengths

  • Low compounded entry — tirzepatide $179/mo, microdose from $149, 3-month plans from $199
  • Available in all 50 states
  • Keeps a brand-name path open (Ozempic listed at $1,299)
  • HRT and menopause care available alongside GLP-1

Where it loses points

  • Compounded formulations are not FDA-approved
  • Brand-name Ozempic is priced steeply at $1,299
  • No oral or sublingual route offered yet
  • Newer operator (Gala GLP-1 by AI Coaching Inc) with a shorter public record

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 37 providers, CoreAge Rx grades highest at 94/100 (A). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard